Role of α5β1 integrin up-regulation in radiation-induced invasion by human pancreatic cancer cells

Translational Oncology

Volumn 4, Issue 5, 2011, Pages 282-292

  Yao, Hongren ^a   Zeng, Zhao Zhu ^a   Fay, Kevin S ^a   Veine, Donna M ^a   Staszewski, Evan D ^a   Morgan, Meredith ^a   Wilder Romans, Kari ^a   Williams, Terence M ^a   Spalding, Aaron C ^b   Ben Josef, Edgar ^a   Livant, Donna L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Norton Cancer Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VERY LATE ACTIVATION ANTIGEN 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASEMENT MEMBRANE; CANCER CELL CULTURE; CANCER INVASION; CANCER RADIOTHERAPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IONIZING RADIATION; MOUSE; NONHUMAN; PANCREAS CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; UPREGULATION;

EID: 80053376721     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.11133     Document Type: Article

References (44)

1. Iacobuzio-Donahue CA, Fu B, Yachida S, Luo M, Abe H, Henderson CM, Vilardell F, Wang Z, Keller JW, Banerjee P, et al. (2009). DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol 27, 1806-1813.
2. Cardenes HR, Chiorean EG, Dewitt J, Schmidt M, and Loehrer P (2006). Locally advanced pancreatic cancer: current therapeutic approach. Oncologist 11, 612-623.
3. Chang BW, Siccion E, and Saif MW (2010). Updates in locally advanced pancreatic cancer. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010. JOP 11, 313-316.
4. Baluna RG, Eng TY, and Thomas CR (2006). Adhesion molecules in radiotherapy. Radiat Res 166, 819-831.
5. Wild-Bode C, Weller M, Rimner A, Dichgans J, and Wick W (2001). Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 61, 2744-2750.
6. Meineke V, Gilbertz KP, Schilperoort K, Cordes N, Sendler A, Moede T, and van Beuningen D (2002). Ionizing radiation modulates cell surface integrin expression and adhesion of COLO-320 cells to collagen and fibronectin in vitro. Strahlenther Onkol 178, 709-714.
7. Jia Y, Zeng ZZ, Markwart SM, Rockwood KF, Ignatoski KM, Ethier SP, and Livant DL (2004). Integrin fibronectin receptors in matrix metalloproteinase-1- dependent invasion by breast cancer and mammary epithelial cells. Cancer Res 64, 8674-8681.
8. Livant DL, Brabec RK, Pienta KJ, Allen DL, Kurachi K, Markwart S, and Upadhyaya A (2000). Anti-invasive, antitumorigenic, and antimetastatic activities of the PHSCN sequence in prostate carcinoma. Cancer Res 60, 309-320.
9. Zeng Z-Z, Jia YF, Hahn NJ, Markwart SM, Rockwood KF, and Livant DL (2006). Role of focal adhesion kinase and phosphatidylinositol 3′-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1 dependent invasion by metastatic prostate cancer cells. Cancer Res 66, 8091-8099.
10. 1 integrin ligand PHSRN induces invasion and α5 mRNA in endothelial cells to stimulate angiogenesis. Transl Oncol 2, 8-20.
11. Livant DL, Brabec RK, Kurachi K, Allen DL, Wu Y, Haaseth R, Andrews P, Ethier SP, and Markwart S (2000). The PHSRN sequence induces extracellular matrix invasion and accelerates wound healing in obese diabetic mice. J Clin Invest 105, 1537-1545.
12. 1 integrins. Mol Cell Biol 24, 1505-1515.
13. Murk JL, Stoorvogel W, Kleijmeer MJ, and Geuze HJ (2002). The plasticity of multivesicular bodies and the regulation of antigen presentation. Semin Cell Dev Biol 13, 303-311.
14. Tan MH, Nowak NJ, Loor R, Ochi H, Sandberg AA, Lopez C, Pickren JW, Berjian R, Douglass HO Jr, and Chu TM (1986). Characterization of a new primary human pancreatic tumor line. Cancer Invest 4, 15-23.
15. Lieber M, Mazzetta J, Nelson-Rees W, Kaplan M, and Todaro G (1975). Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas. Int J Cancer 15, 741-747.
16. Wu M, Arimura GK, and Yunis AA (1977). Purification and characterization of a plasminogen activator secreted by cultured human pancreatic carcinoma cells. Biochemistry 16, 1908-1913.
17. Cheng S, Tada M, Hida Y, Asano T, Kuramae T, Takemoto N, Hamada J, Miyamoto M, Hirano S, Kondo S, et al. (2008). High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma. J Surg Res 146, 104-109.
18. Albertin G, Ruggero M, Guidolin D, and Nussdorfer GG (2006). Gene silencing of human RAMP2 mediated by short-interfering RNA. Int J Mol Med 18, 531-535.
19. Zhou S-Y, Lu Y-X, Yao H, and Owyang C (2008). Spatial organization of neurons in the dorsal motor nucleus of the vagus synapsing with intragastric cholinergic and nitric oxide/VIP neurons in the rat. Am J Physiol Gastrointest Liver Physiol 294, G1201-G1209.
20. Li Y, Wu X, Yao H, and Owyang C (2005). Secretin activates vagal primary afferent neurons in the rat: evidence from electrophysiological and immunohistochemical studies. Am J Physiol Gastrointest Liver Physiol 289, G745-G752.
21. Chakraborty TR, Ng L, and Gore AC (2003). Age-related changes in estrogen receptor β in rat hypothalamus: a quantitative analysis. Endocrinology 144, 4164-4171.
22. Oo TF, Henchcliffe C, James D, and Burke RE (1999). Expression of c-fos, c-jun, and c-jun N-terminal kinase (JNK) in a developmental model of induced apoptotic death in neurons of the substantia nigra. J Neurochem 72, 557-564.
23. Ng T, Shima D, Squire A, Bastiaens PI, Gschmeissner S, Humphries MJ, and Parker PJ (1999). PKCα regulates β1 integrin-dependent cell motility through association and control of integrin traffic. EMBO J 18, 3909-3923.
24. Spang A (2009). On the fate of early endosomes. Biol Chem 390, 753-759.
25. van Weert AW, Geuze HJ, Groothuis B, and Stoorvogel W (2000). Primaquine interferes with membrane recycling from endosomes to the plasma membrane through a direct interaction with endosomes which does not involve neutralisation of endosomal pH nor osmotic swelling of endosomes. Eur J Cell Biol 79, 394-399.
26. Chung HW, Wen J, Lim JB, Bang S, Park SW, and Song SY (2009). Radiosensitization effect of STI-571 on pancreatic cancer cells in vitro. Int J Radiat Oncol Biol Phys 75, 862-869.
27. Konduri S, Colon J, Baker CH, Safe S, Abbruzzese JL, Abudayyeh A, Basha MR, and Abdelrahim M (2009). Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression. Mol Cancer Ther 8, 533-542.
28. Song X, Wang H, Logsdon CD, Rashid A, Fleming JB, Abbruzzese JL, Gomez HF, and Evans DB (2011). Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma. Cancer 117, 734-743.
29. Morgan MA, Parsels LA, Kollar LE, Normolle DP, Maybaum J, and Lawrence TS (2008). The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancer. Clin Cancer Res 14, 5142-5149.
30. Morgan MA, Parsels LA, Zhao L, Parsels JD, Davis MA, Hassan MC, Arumugarajah S, Hylander-Gans L, Morosini D, Simeone DM, et al. (2010). Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair. Cancer Res 70, 4972-4981.
31. Tsutsumi K, Tsuda M, Yazawa N, Nakamura H, Ishihara S, Haga H, Yasuda M, Yamazaki R, Shirato H, Kawaguchi H, et al. (2009). Increased motility and invasiveness in tumor cells that survive 10 Gy irradiation. Cell Struct Funct 34, 89-96.
32. 1 and fibronectin. Cancer Res 70, 5238-5248.
33. Qian LW, Mizumoto K, Urashima T, Nagai E, Maehara N, Sato N, Nakajima M, and Tanaka M (2002). Radiation-induced increase in invasive potential ofhuman pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. Clin Cancer Res 8, 1223-1227.
34. Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB, and Logsdon CD (2008). Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 68, 918-926.
35. Hallahan DE, Staba-Hogan MJ, Virudachalam S, and Kolchinsky A (1998). X-ray-induced P-selectin localization to the lumen of tumor blood vessels. Cancer Res 58, 5216-5220.
36. Kawana A, Shioya S, Katoh H, Tsuji C, Tsuda M, and Ohta Y (1997). Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 on alveolar macrophages in the acute stage of radiation-induced lung injury in rats. Radiat Res 147, 431-436.
37. Aota S, Nagai T, and Yamada KM (1991). Characterization of regions of fibronectin besides the arginine-glycine-aspartic acid sequence required for adhesive function of the cell-binding domain using site-directed mutagenesis. J Biol Chem 266, 15938-15943.
38. 1-fibronectin interactions using inhibitory anti-α5 and anti-β1 monoclonal antibodies. Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the α5 subunit. J Biol Chem 272, 17283-17292.
39. Khalili P, Arakelian A, Chen G, Plunkett ML, Beck I, Parry GC, Donate F, Shaw DE, Mazar AP, and Rabbani SA (2006). A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo. Mol Can Ther 5, 2271-2280.
40. 1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice. Int J Cancer 104, 496-503.
41. van Golen KL, Bao L, Brewer GJ, Pienta KJ, Kamradt JM, Livant DL, and Merajver SD (2002). Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma. Neoplasia 4, 373-379.
42. Cianfrocca ME, Kimmel KA, Gallo J, Cardoso T, Brown MM, Hudes G, Lewis N, Weiner L, Lam GN, Brown SC, et al. (2006). Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a β integrin antagonist, in patients with solid tumours. Br J Cancer 94, 1621-1626.
43. Yao H, Veine D, Fay K, Staszewski E, Zeng Z-Z, and Livant D (2011). The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation. Breast Cancer Res Treat 125, 363-375.
44. Yao H, Veine DM, Zeng ZZ, Fay KS, Staszewski ED, and Livant DL (2010). Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formation. Clin Exp Metastasis 27, 173-184.